This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing standard of care for SMA and potential of PTC Therapeutics' Evrysdi
Ticker(s): PTCT, RHHBYWho's the expert?
Institution: CHI St Alexius Hospital Bismarck
- Highly qualified Neurologist experienced in diagnosing and treating Neurological and Psychiatric conditions in both adult and pediatric neurology patients
- Background includes seeing patients with epilepsy, stroke care ( acute and chronic ), traumatic brain and spine injuries, dementia, post-concussive syndrome, neuropathies, pain syndromes, headaches & neuromuscular disorders
- Currently manages about 50 patients with spinal motor neuron disease and prescribes Evrysdi for 18 patients
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
